○Atsushi Kato¹, Izumi Nakagome², Maki Kise¹, Kousuke Yoshimura¹, Takuya Okada³, Naoki Toyooka³, Nobutada Tanaka² (1. Department of Hospital Pharmacy, University of Toyama, 2. School of Pharmaceutical Sciences, Kitasato University , 3. Graduate School of Science and Engineering, University of Toyama)

○Izumi Nakagome¹, Atsushi Kato², Maki Kise², Yuna Shimadate², Tomoki Yoshida¹, Noriyuki Yamaotsu¹, Nobutada Tanaka¹ (1. Kitasato Univ., Sch. Pharm., 2. Department of Hospital Pharmacy, University of Toyama)

○Minami Fujita^1,2, Amika Kikuchi¹, Kyohei Arita¹, Takashi Misawa², Yosuke Demizu^1,2 (1. Grad. Sch. Med. Life Sci., Yokohama City Univ., 2. NIHS)

○Seyed Amirhossein Tabatabaei Dakhili¹, Kunyan Yang¹, Rabih Abou Farraj², Hamdah Al-Nebaihi¹, Christina Saed¹, Rakesh Bhat², Amanda Greenwell¹, Jordan Chan¹, Indiresh Mangra-Bala¹, Keshav Gopal¹, Tanin Shafaati¹, Farah Eaton¹, Sally Ferrari¹, Carlos Velazquez-Martinez¹, MIchael Overduin², Mark Glover², Dion Brocks¹, John Ussher¹ (1. Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada., 2. Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.)

○Daisuke Yasuda¹, Daisuke Inoue¹, Mayu Sugimoto¹, Kazuma Kaitoh², Tomoyuki Ohe³, Tomoya Hirano¹ (1. Fac. Pharm., Osaka Med. and Pharm. Univ., 2. Grad. Sc. Inf., Nagoya Univ., 3. Fac. Pharm., Keio Univ.)

○Aya Makino¹, Kaori Ota¹, Makoto Furutachi¹ (1. Pharm. Sci., Fukuoka Univ.)

○Taiki Matsusaki¹, Kaori Ota¹, Takanori Kitaguchi², Toshiyuki Tsunoda², Makoto Furutachi¹ (1. Pharm. Sci., Fukuoka Univ., 2. Med., Fukuoka Univ.)

○Rina Matsuda¹, Kaori Ota¹, Makoto Furutachi¹ (1. Pharm. Sci., Fukuoka Univ.)

○Ryo Yonezawa¹, Kotaro Ochiai¹, Hiroyuki Kagechika¹, Shinya Fujii¹ (1. IBB, Tokyo Medical and Dental Univ)

○Saho Machida¹, Takuya Kobayakawa¹, Masaru Yokoyama², Masayuki Fujino³, Moemi Kaneko¹, Masaki Kuraue¹, Sayaka Baku¹, Takato Onishi¹, Osamu Kotani², Kouhei Tuji¹, Tsutomu Murakami³, Hironori Satou², Hirokazu Tamamura¹ (1. Institute of Biomaterials and Bioengineering (IBB), Tokyo Medical and Dental Univ., 2. Pathogen Genomics Center, National Institute of Infectious Diseases, 3. AIDS Research Center, National Institute of Infectious Diseases)

○Tomohiro Suzuki¹, Akari Ikeda^1,2, Masako Honsho^1,2, Yoshihiko Noguchi^1,2, Kiki Nakazato¹, Koudai Tomiyama¹, Yoshiki Ikegaya¹, Yukihiro Asami^1,2, Tomoyasu Hirose^1,2, Toshiaki Sunazuka^1,2 (1. Grad. Sch. of Infect. Ctl., Kitasato Univ., 2. Ōmura Satoshi Memorial Inst., Kitasato Univ.)

○Yuki Kuroda¹, Takuya Kobayakawa¹, Kohei Tsuji¹, Kiju Konno¹, Nami Ohashi^1,2, Ami Masuda¹, Yutaro Miura¹, Takeo Kuwata³, Kazuhisa Yoshimura⁴, Tomoyuki Miura⁵, Shigeyoshi Harada⁶, Shuzo Matsushita³, Hirokazu Tamamura¹ (1. Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2. Showa Pharmaceutical University, 3. Joint Research Center for Human Retrovirus Infection, 4. Tokyo Metropolitan Institute of Public Health, 5. Institute for Frontier Life and Medical Sciences, Kyoto University, 6. AIDS Research Center, National Institute of Infectious Diseases)

○Yuki Inomata¹, Koji Uwai¹ (1. Muroran Institute of Technology, Muroran Institute of Technology, Graduate School of Engineering)

○Toshihiko Sawada^1,2, Tomohiro Hashimoto², Hiroaki Wasada² (1. xenoBiotic Inc., 2. Faculty of Regional Studies, Gifu Univ.)

○MASASHI Takano¹, KAORI Yasuda², HIROKI Mano², TOSHIYUKI Sakaki², ATSUSHI Kittaka¹ (1. Teikyo Univ., 2. Toyama Pref. Univ.)

○Akari Tokuyama¹, Yasunobu Yamashita¹, Ryo Maeda², Yuri Takada¹, Yukihiro Itoh¹, Makoto Tachibana², Takayoshi Suzuki¹ (1. SANKEN, Osaka Univ., 2. FBS, Osaka Univ.)

○Naoki Yamada¹, Yasuyuki Tsunoi¹ (1. National Defense Medical College)

○Mirei Hayashi¹, Yukihiro Itoh¹, Yasunobu Yamashita¹, Yuri Takada¹, Takayoshi Suzuki¹ (1. SANKEN, Osaka Univ.)

○Yosuke Kikuchi¹, Tadahaya Mizuno¹, Shumpei Nemoto¹, Hiroyuki Kusuhara¹ (1. Grad. Sch. Pharm. Sci., The University of Tokyo)

○Hironobu Hayashi¹, Sai Nagaoka², Yukito Umeno¹, Chiharu Kurumada¹, Miku Watanabe¹, Taiki Ichida², Hisashi Murakami², Naohisa Ogo², Akira Asai² (1. Division of Pharmaceutical Sciences, Univ. of Shizuoka, 2. Graduate Division of Pharmaceutical Sciences, Univ. of Shizuoka)

○Hisashi Murakami¹, Katsumi Ohta¹, Yasushi Takebayashi^1,2, Suzuka Makita¹, Naohisa Ogo¹, Akira Asai¹ (1. Grad. Div. Pharm. Sci., Univ. Shizuoka, 2. Nippon Light Metal Company, Ltd.)

○Shuhei Nakao¹, Kenta Yamaoka², Tadashi Shimizu¹, Yuzuki Moriyama¹, Ken-ichi Kiyomiya¹ (1. Sch. Pharm. Hyogo Medical Univ., 2. Kobe City Medical Center General Hosp.)

○yusuke yagi^1,3,4, Hiroyuki Kimura², Takahiro Higuchi^3,4 (1. Kyoto College of Medical Science, 2. Grad. Sch. Pharm. Sci., Kyoto Pharmaceutical Univ., 3. Comprehensive Heart Failure Center, University Hospital of Würzburg, 4. Grad. Sch. Med. Dent. Pharm. Sci., Okayama Univ.)

○Kano Komiyama¹, Yukito Iio¹, Makoto Sato¹, Azusa Nakayama¹, Yuka Nakai¹, Shiho Usui¹, Moe Kouma¹, Tomohiro Takahashi¹, Hanae Mitsutake¹, Yasuhiro Kajiwara¹ (1. Dept. Pharm. Sci., Yokohama Univ. Pharm.)

○Genichiro Tsuji¹, Takashi Kurohara¹, Hidetomo Yokoo¹, Sayaka Masada¹, Nahoko Uchiyama¹, Eiichi Yamamoto¹, Yosuke Demizu^1,2,3 (1. National Institute of Health Sciences, 2. Grad. Sch. Med., Dent. Pharm. Sci., Okayama Univ., 3. Grad. Sch. Med. Life Sci., Yokohama City Univ.)

○Shun-ichi Wada¹, Azusa Yamada¹, Junsuke Hayashi¹, Hidehito Urata¹ (1. Fac. Pharm, Osaka Med. Pharm. Univ.)